Search results
Results from the WOW.Com Content Network
After a time, certain colonies began to grow. However, the EbgA protein is an ineffective lactase and does not allow growth on lactose. Two classes of single point mutations dramatically improve the activity of ebg enzyme toward lactose. [24] [25] and, as a result, the mutant enzyme is able to replace the lacZ β-galactosidase. [26]
The treatment is also known as pancreatic enzyme replacement therapy or PERT. [6] Common side effects include vomiting, abdominal pain, constipation, and diarrhea. [3] Other side effects include perianal irritation and high blood uric acid. [5] The enzymes are from pigs. [5] Use is believed to be safe during pregnancy. [5]
Lactase (EC 3.2.1.108) is an enzyme produced by many organisms and is essential to the complete digestion of whole milk. It breaks down the sugar lactose into its component parts, galactose and glucose. Lactase is found in the brush border of the small intestine of humans and other mammals.
Substrate reduction therapy is FDA approved and there is at least one treatment available on the market. [10] Gene therapy aims to replace a missing protein in the body through the use of vectors, usually viral vectors. [11] In gene therapy, a gene encoding for a certain protein is inserted into a vector. [11]
A 2015 Cochrane review found unclear usefulness for cancer pain, [44] though other reviews have found tentative evidence of benefit. [45] [46] It is of unclear effect in hot flashes in people with breast cancer. [47] The effects of aromatherapy are unclear with no peer-reviewed research in regards to cancer treatment. [48]
Saccharomyces boulardii is a tropical yeast first isolated from lychee and mangosteen peels in 1923 by French scientist Henri Boulard.Although early reports claimed distinct taxonomic, metabolic, and genetic properties, [1] S. boulardii is a grouping of S. cerevisiae strains, all sharing a >99% genomic relatedness.
William Donald Kelley (November 1, 1925 – January 30, 2005) was an American orthodontist who developed "non-specific metabolic therapy," [1] an alternative cancer treatment, now known to be ineffective, which he based on his personal belief that "wrong foods [cause] malignancy to grow, while proper foods [allow] natural body defenses to work."
α-Galactosidase ( EC 3.2.1.22, α-GAL, α-GAL A; systematic name α-D-galactoside galactohydrolase) is a glycoside hydrolase enzyme that catalyses the following reaction: [1] Hydrolysis of terminal, non-reducing α- D -galactose residues in α- D -galactosides, including galactose oligosaccharides, galactomannans and galactolipids